Navigation Links
The Conference Forum Announces A New Medicaid Rebate Summit for Early 2013

New York, New York (PRWEB) December 19, 2012

The Conference Forum, recognized in the pharmaceutical industry for its interactive-style meetings, announced a new conference to navigate the complexities of the Medicaid Rebate process. The Medicaid Rebate Summit brings manufacturers together with State Medicaid and Pharmacy leaders to work through the interpretation of the anticipated Final Rule, the larger implications of health care reform and its financial and operational impact as well as resolutions for disputes.

Alice Valder Curran of Hogan Lovells opens the program with remarks on interpreting the Final Rule – a “hot” topic for 2013. The 2013 Medicaid Rebate Summit fosters relationships between drug manufactures and state agencies in order to better serve the Medicaid population. Attendees will:

  • Hear pertinent Health Care Association insights on health care reform and POVs from Managed Markets, Government Contracting, Pricing and Reimbursement, States and Consultants.
  • Participate in a Q&A with CMS representation lead by LaDonna Steiner of Purdue Pharma.

The conference has two track choices to allow individual event customization. Track One, chaired by Heather Dixson, Director Government Price Reporting, Eli Lilly & Co will address interpretation and implementation of the Final Rule. Track Two, chaired by Ed McAdam, Senior Director, Pricing & Analytics, Daiichi Sankyo, Inc. will focus on 340B, Government Pricing and Reimbursement.

When speaking about his involvement McAdams said, “With all of the pending changes around government pharmaceutical programs this conference brings together leading industry and government experts all in one place to provide you with valuable insight into the future.”

Event Details:

Medicaid Rebate Summit
Date: February 14-15, 2013
Location: Park Hyatt Washington, Washington, DC
Click here to register.

Pre-Conference Medicaid Rebate Bootcamp
The workshop is designed for professionals either new to the Medicaid Rebate space or
for those looking for a refresher course on the basics.
Date: February 13, 2013
Location: Park Hyatt Washington, Washington, DC
Click here to register.

For program details click here
Questions, please email service(at)theconferenceforum(dot)org

Speakers Include:

  • Derek Asay, Eli Lilly & Co.
  • George Bilyk, Janssen
  • JoAnn Bute, Amneal Pharmaceuticals
  • Kevin Cast, Express Scripts
  • Chris Cobourn, CIS
  • Cori Cooper, PharmD, Wyoming Department of Health
  • Thomas Corcoran, Assistant US Attorney, District of Maryland
  • John Coster, PhD, RPh, National Community Pharmacists Association
  • Alice Valder Curran, Hogan Lovells
  • Tarra DeShields, Assistant U.S. Attorney, Civil Division, District of Maryland
  • Heather Dixson Eli Lilly & Co.
  • Audrey Fletcher, CIS
  • Sharon Greeson, RPh, HP
  • Edmund Haislmaier, Heritage Foundation
  • Christopher A. Hatwig, MS, RPh, FASHP, APEXUS/ 340B Prime Vendor
  • Mike Hepburn, Janssen R&D, LLC
  • Rich Holsapple, RPh, Oregon MMIS, HP Enterprise Services
  • Christopher Jackson, Bayer HealthCare LLC
  • Ann Kaplan, PhRMA
  • Julie Khani, National Association of Chain Drug Stores
  • Mitch Lazris, Hogan Lovells
  • Lori Martin, Eli Lilly & Co.
  • Paula Martins, Daiichi Sankyo, Inc.
  • Jesse Mensah, Celgene
  • Ed McAdam, Daiichi Sankyo, Inc.
  • Lisa McNair, Reckitt Benckiser
  • Jennifer Norton, Vertex Pharmaceuticals, Inc.
  • Brian Osberg, National Governors Association
  • Viveca Parker, Assistant US Attorney, Civil Division United States,
Eastern District of PA
  • DR Krista Pedley, HRSA Office of Pharmacy Affairs
  • Erica Petersohn, CIS
  • Bill Phillips, CIS
  • Joann S. Prushinski, Genentech, Inc.
  • Kent Rogers, MBA, Acorda Therapeutics
  • Matt Sheffield, Boehringer Ingelheim Pharmaceuticals, Inc.
  • LaDonna Steiner, Purdue Pharma
  • Laurel Todd, MBA, BIO

About The Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference
2. EastBridge Investment Group and CBMG attended SeeThruEquity Investor Conference in New York
3. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at
4. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at
5. Auxilium Pharmaceuticals, Inc. to Present At The Oppenheimer 23rd Annual Growth Conference
6. Pinnaclife Animal Health to attend CVC Conference in San Diego
7. Marrone Bio Innovations’ CEO to Address European Biopesticide Industry at Informa Life Sciences Biopesticides Conference
8. Palatin Technologies, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference
9. Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference
10. Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on November 14, 2012
Post Your Comments:
(Date:10/13/2015)... NEW YORK , October 13, 2015 ... biotechnology acceleration and development company, has entered into a ... New York and Paris, France ... --> --> This collaborative ... a highly respected scientific advisory team as well as ...
(Date:10/13/2015)... TORONTO , Oct. 13, 2015  Generex Biotechnology ... has entered into a non-binding Letter of Intent (LOI) with ... that has developed a proprietary cooling technology designed to improve ... the United States and three million ... of 25 and 44 diagnosed as infertile.  For 42% of ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... focused ultrasound (HIFU) technologies, announced today that it received de novo clearance from ... in the U.S. for the ablation of prostate tissue. Sonablate® is the first ...
(Date:10/13/2015)... 13, 2015 the United States ... .  PRCC represents about 14% of all new cases of kidney ... Canada and Europe . ...   --> Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) ... and AstraZeneca AB (publ) ("AstraZeneca") have completed enrolment in a global ...
Breaking Biology Technology:
(Date:9/30/2015)... 30, 2015  The global glucose monitoring device and diabetes ... says a new report on the industry from Kalorama Information. Sales ... the market, followed by continuous glucose monitoring and sensor segment, ... market for these products in its latest report, The ... , ...
(Date:9/28/2015)... NEW YORK , Sept. 28, 2015 ... platform, announced today that its expedited traveler ...  CLEAR,s innovative platform transforms travel, bringing a ... for its members. "CLEAR offers ... which enhances customer service," said Jim ...
(Date:9/28/2015)... , September 28, 2015 ... Component (Hardware & Software), Product (Scanner & Others), Application ... & Defense, & Others) & Geography Global - Forecast ... expected to reach USD 3627.90 Million by 2020, at ... Browse 65 market data T ables ...
Breaking Biology News(10 mins):